{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T06:06:41Z","timestamp":1784700401738,"version":"3.55.0"},"reference-count":109,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>High-grade gliomas cannot be fully understood without considering the biology of aging. In this study, we demonstrate that a set of genes previously established as predictors of tumor subtype and patient survival in gliomas can also be independently characterized as biomarkers associated with aging. Moreover, their expression changes during aging parallel with those seen in malignant transformation: genes which upregulation worsen prognosis are also upregulated with age. These findings support the hypothesis that glioma progression and aging share partially overlapping molecular mechanisms. We also demonstrate that while accelerated epigenetic and mitotic senescence \u2013 gauged by mathematical models (biological clocks) that track aging through specific changes in the DNA methylation of a set of CpG sites \u2013 appears inherent to various molecular variants of gliomas, its nature and prognostic significance vary depending on the specific subtype and the epigenetic clock model employed. Moreover, accelerated aging does not represent a universal hallmark of aggressiveness but rather a phenomenon specific to individual glioma subtype. In this paper, we provide a detailed discussion of the role of cellular senescence in glioma pathogenesis, with a particular focus on its key contribution to tumor growth control and therapeutic response. Additionally, we highlight the yet unresolved question of whether age-associated inflammation (inflammaging) acts as an independent driver of glioma progression or whether the tumor itself accelerates aging, and suggest the potential of profiling patients cellular aging in developing personalized treatment strategies.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1898095","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T05:53:29Z","timestamp":1784699609000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Towards a personalized perspective on gliomas: an epigenetic-immuno-inflammatory aging framework"],"prefix":"10.3389","volume":"17","author":[{"given":"Olga","family":"Vershinina","sequence":"first","affiliation":[{"name":"Research Center in Artificial Intelligence, Institute of Information Technologies, Mathematics and Mechanics, Lobachevsky State University","place":["Nizhny Novgorod, Russia"]},{"name":"Institute of Biogerontology, Lobachevsky State University","place":["Nizhny Novgorod, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Turubanova","sequence":"additional","affiliation":[{"name":"Department of Genetics and Life Sciences, Sirius University","place":["Sochi, Russia"]},{"name":"Institute of Neurosciences, Lobachevsky State University","place":["Nizhny Novgorod, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Franceschi","sequence":"additional","affiliation":[{"name":"Institute of Biogerontology, Lobachevsky State University","place":["Nizhny Novgorod, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikhail","family":"Ivanchenko","sequence":"additional","affiliation":[{"name":"Research Center in Artificial Intelligence, Institute of Information Technologies, Mathematics and Mechanics, Lobachevsky State University","place":["Nizhny Novgorod, Russia"]},{"name":"Institute of Biogerontology, Lobachevsky State University","place":["Nizhny Novgorod, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41572-024-00516-y","article-title":"Glioma","volume":"10","author":"Weller","year":"2024","journal-title":"Nat Rev Dis Primer"},{"key":"B2","doi-asserted-by":"publisher","first-page":"4233","DOI":"10.1038\/s41467-025-59156-9","article-title":"Genomic landscape of diffuse glioma revealed by whole genome sequencing","volume":"16","author":"Kinnersley","year":"2025","journal-title":"Nat Commun"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO classification of tumors of the central nervous system: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro-Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.17305\/bb.2025.12598","article-title":"In silico analysis reveals distinct changes in markers of epithelial to mesenchymal transition in glioma subtypes","volume":"25","author":"Pe\u0107ina-\u0160laus","year":"2025","journal-title":"Biomol BioMed"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14133161","article-title":"Survival outcomes and prognostic factors in glioblastoma","volume":"14","author":"Brown","year":"2022","journal-title":"Cancers"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0389-3","article-title":"Human glioblastoma arises from subventricular zone cells with low-level driver mutations","volume":"560","author":"Lee","year":"2018","journal-title":"Nature"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16081557","article-title":"Glioma stem cells\u2014features for new therapy design","volume":"16","author":"Pe\u0107ina-\u0160laus","year":"2024","journal-title":"Cancers"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2026.105187","article-title":"Neural stem cells and glioblastoma stem cells: redefining concepts","volume":"220","author":"Arce","year":"2026","journal-title":"Crit Rev Oncol Hematol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.cell.2019.06.024","article-title":"An integrative model of cellular states, plasticity, and genetics for glioblastoma","volume":"178","author":"Neftel","year":"2019","journal-title":"Cell"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.615704","article-title":"Glioma stem cells as immunotherapeutic targets: advancements and challenges","volume":"11","author":"Piper","year":"2021","journal-title":"Front Oncol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2022.10.010","article-title":"Neuronal and tumourigenic boundaries of glioblastoma plasticity","volume":"9","author":"De Silva","year":"2023","journal-title":"Trends Cancer"},{"key":"B12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.arr.2014.10.004","article-title":"DAMPs, ageing, and cancer: the \u2018DAMP hypothesis\u2019","volume":"24","author":"Huang","year":"2015","journal-title":"Ageing Res Rev"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2017.03.008","article-title":"Aging and cancer: the role of macrophages and neutrophils","volume":"36","author":"Jackaman","year":"2017","journal-title":"Ageing Res Rev"},{"key":"B14","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.smim.2018.10.011","article-title":"Aging, inflammation and cancer","volume":"40","author":"Bottazzi","year":"2018","journal-title":"Semin Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/noaf194","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2018\u20132022","volume":"27","author":"Price","year":"2025","journal-title":"Neuro-Oncol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.12.028","article-title":"Molecular profiling reveals biologically discrete subsets and pathways of progression in diffuse glioma","volume":"164","author":"Ceccarelli","year":"2016","journal-title":"Cell"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2024.1446428","article-title":"Epigenetic clocks and gliomas: unveiling the molecular interactions between aging and tumor development","volume":"11","author":"Chen","year":"2024","journal-title":"Front Mol Biosci"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noy003","article-title":"Models of epigenetic age capture patterns of DNA methylation in glioma associated with molecular subtype, survival, and recurrence","volume":"20","author":"Liao","year":"2018","journal-title":"Neuro-Oncol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0236045","article-title":"Epigenetic age acceleration and clinical outcomes in gliomas","volume":"15","author":"Zheng","year":"2020","journal-title":"PloS One"},{"key":"B20","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s40478-022-01344-5","article-title":"DNA methylation-based age acceleration observed in IDH wild-type glioblastoma is associated with better outcome\u2014including in elderly patients","volume":"10","author":"Bady","year":"2022","journal-title":"Acta Neuropathol Commun"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-024-01793-w","article-title":"DNA methylation-based analysis reveals accelerated epigenetic aging in giant cell-enriched adult-type glioblastoma","volume":"16","author":"Cakmak","year":"2024","journal-title":"Clin Epigenet"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nov243","article-title":"Selective coexpression of VEGF receptor 2 in EGFRvIII-positive glioblastoma cells prevents cellular senescence and contributes to their aggressive nature","volume":"18","author":"Jones","year":"2016","journal-title":"Neuro-Oncol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13071560","article-title":"Residual disease in glioma recurrence: a dangerous liaison with senescence","volume":"13","author":"Putavet","year":"2021","journal-title":"Cancers"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3390\/cancers18040550","article-title":"The paradox of senescence in glioblastoma: SASP as an emerging cancer hallmark","volume":"18","author":"Tarumi","year":"2026","journal-title":"Cancers"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1097\/00006123-200112000-00002","article-title":"Age and radiation response in glioblastoma multiforme","volume":"49","author":"Barker","year":"2001","journal-title":"Neurosurgery"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(12)70265-6","article-title":"Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial","volume":"13","author":"Malmstr\u00f6m","year":"2012","journal-title":"Lancet Oncol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/s13014-019-1389-7","article-title":"Survival benefits of hypofractionated radiotherapy combined with temozolomide or temozolomide plus bevacizumab in elderly patients with glioblastoma aged \u2265 75 years","volume":"14","author":"Ohno","year":"2019","journal-title":"Radiat Oncol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1007\/s11060-025-05395-1","article-title":"Glioblastoma immunotherapy in the context of the aging immune system: a systematic review and meta-analysis","volume":"176","author":"Shireman","year":"2026","journal-title":"J Neuro-Oncol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1093\/noajnl\/vdaf222","article-title":"Age-dependent glioma progression and functional decline in a syngeneic murine model: host vulnerabilities and opportunities for targeted intervention","volume":"8","author":"Leblanc","year":"2026","journal-title":"Neuro-Oncol Adv"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgo.2014.08.003","article-title":"Senescence-associated-gene signature identifies genes linked to age, prognosis, and progression of human gliomas","volume":"5","author":"Coppola","year":"2014","journal-title":"J Geriatr Oncol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.18632\/aging.203008","article-title":"Aging-related genes are potential prognostic biomarkers for patients with gliomas","volume":"13","author":"Xiao","year":"2021","journal-title":"Aging"},{"key":"B32","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12920-023-01538-3","article-title":"Analysis and validation of aging-related genes in prognosis and immune function of glioblastoma","volume":"16","author":"Mu","year":"2023","journal-title":"BMC Med Genomics"},{"key":"B33","doi-asserted-by":"publisher","first-page":"9540","DOI":"10.1038\/s41598-025-93482-8","article-title":"Comprehensive analysis of senescence-related genes identifies prognostic clusters with distinct characteristics in glioma","volume":"15","author":"Wei","year":"2025","journal-title":"Sci Rep"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17162614","article-title":"Explainable machine learning models for glioma subtype classification and survival prediction","volume":"17","author":"Vershinina","year":"2025","journal-title":"Cancers"},{"key":"B35","doi-asserted-by":"publisher","first-page":"4030","DOI":"10.1016\/j.cell.2024.05.048","article-title":"TERT activation targets DNA methylation and multiple aging hallmarks","volume":"187","author":"Shim","year":"2024","journal-title":"Cell"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2006.10.011","article-title":"Aging: a revisited theory based on free radicals generated by NOX family NADPH oxidases","volume":"42","author":"Krause","year":"2007","journal-title":"Exp Gerontol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2014.6221","article-title":"NOX4 NADPH oxidase-dependent mitochondrial oxidative stress in aging-associated cardiovascular disease","volume":"23","author":"Vendrov","year":"2015","journal-title":"Antioxid Redox Signal"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2017.05.007","article-title":"The role of matrix metalloproteinases in aging: tissue remodeling and beyond","volume":"1864","author":"Freitas-Rodr\u00edguez","year":"2017","journal-title":"Biochim Biophys Acta BBA - Mol Cell Res"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.5582\/irdr.2016.01028","article-title":"Inflammageing assessed by MMP9 in normal Japanese individuals and the patients with Werner syndrome","volume":"5","author":"Goto","year":"2016","journal-title":"Intractable Rare Dis Res"},{"key":"B40","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.1038\/s41467-019-11031-0","article-title":"Neuroepigenetic signatures of age and sex in the living human brain","volume":"10","author":"Gilbert","year":"2019","journal-title":"Nat Commun"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1080\/14728222.2022.2158081","article-title":"High levels of HDAC expression correlate with microglial aging","volume":"26","author":"Auzmendi-Iriarte","year":"2022","journal-title":"Expert Opin Ther Targets"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2018.00153","article-title":"Integrative analysis of hippocampus gene expression profiles identifies network alterations in aging and Alzheimer\u2019s disease","volume":"10","author":"Lanke","year":"2018","journal-title":"Front Aging Neurosci"},{"key":"B43","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/s43587-021-00082-y","article-title":"An inflammatory aging clock (iAge) based on deep learning tracks multimorbidity, immunosenescence, frailty and cardiovascular aging","volume":"1","author":"Sayed","year":"2021","journal-title":"Nat Aging"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1007\/s11357-022-00540-4","article-title":"Accelerated epigenetic aging and inflammatory\/immunological profile (ipAGE) in patients with chronic kidney disease","volume":"44","author":"Yusipov","year":"2022","journal-title":"GeroScience"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1177611","article-title":"Small immunological clocks identified by deep learning and gradient boosting","volume":"14","author":"Kalyakulina","year":"2023","journal-title":"Front Immunol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26136284","article-title":"EpInflammAge: epigenetic-inflammatory clock for disease-associated biological aging based on deep learning","volume":"26","author":"Kalyakulina","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2017.00384","article-title":"Adrenomedullin contributes to age-related memory loss in mice and is elevated in aging human brains","volume":"10","author":"Larrayoz","year":"2017","journal-title":"Front Mol Neurosci"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2020.101070","article-title":"Systematic review and analysis of human proteomics aging studies unveils a novel proteomic aging clock and identifies key processes that change with age","volume":"60","author":"Johnson","year":"2020","journal-title":"Ageing Res Rev"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2016.00168","article-title":"Older age results in differential gene expression after mild traumatic brain injury and is linked to imaging differences at acute follow-up","volume":"8","author":"Cho","year":"2016","journal-title":"Front Aging Neurosci"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2019.04.038","article-title":"Aged rats have an altered immune response and worse outcomes after traumatic brain injury","volume":"80","author":"Sun","year":"2019","journal-title":"Brain Behav Immun"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-6165725\/v1","article-title":"Intermittent fasting attenuates CNS inflammaging - rebalancing the transposonome","author":"Cummins","year":"2025"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2024.114943","article-title":"Transcriptomic analysis to identify genes associated with hypothalamus vulnerability in aging mice with cognitive decline","volume":"465","author":"Tian","year":"2024","journal-title":"Behav Brain Res"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2009.10.005","article-title":"Prominent hippocampal CA3 gene expression profile in neurocognitive aging","volume":"32","author":"Haberman","year":"2011","journal-title":"Neurobiol Aging"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2020.02.010","article-title":"MGMT status as a clinical biomarker in glioblastoma","volume":"6","author":"Butler","year":"2020","journal-title":"Trends Cancer"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16071374","article-title":"MGMT methylation and differential survival impact by sex in glioblastoma","volume":"16","author":"Barnett","year":"2024","journal-title":"Cancers"},{"key":"B56","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s40478-019-0744-0","article-title":"Integrative analysis of DNA methylation suggests down-regulation of oncogenic pathways and reduced somatic mutation rates in survival outliers of glioblastoma","volume":"7","author":"Hwang","year":"2019","journal-title":"Acta Neuropathol Commun"},{"key":"B57","doi-asserted-by":"publisher","first-page":"3156","DOI":"10.1186\/gb-2013-14-10-r115","article-title":"DNA methylation age of human tissues and cell types","volume":"14","author":"Horvath","year":"2013","journal-title":"Genome Biol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2012.10.016","article-title":"Genome-wide methylation profiles reveal quantitative views of human aging rates","volume":"49","author":"Hannum","year":"2013","journal-title":"Mol Cell"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1038\/s43587-022-00248-2","article-title":"A computational solution for bolstering reliability of epigenetic clocks: implications for clinical trials and longitudinal tracking","volume":"2","author":"Higgins-Chen","year":"2022","journal-title":"Nat Aging"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.18632\/aging.206098","article-title":"A systematic review of phenotypic and epigenetic clocks used for aging and mortality quantification in humans","volume":"16","author":"Warner","year":"2024","journal-title":"Aging"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2021.101348","article-title":"A systematic review of biological, social and environmental factors associated with epigenetic clock acceleration","volume":"69","author":"Oblak","year":"2021","journal-title":"Ageing Res Rev"},{"key":"B62","doi-asserted-by":"publisher","first-page":"290","DOI":"10.4161\/epi.23924","article-title":"A cell epigenotype specific model for the correction of brain cellular heterogeneity bias and its application to age, brain region and major depression","volume":"8","author":"Guintivano","year":"2013","journal-title":"Epigenetics"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1038\/nn.3588","article-title":"Epigenome-wide differences in pathology-free regions of multiple sclerosis\u2013affected brains","volume":"17","author":"Huynh","year":"2014","journal-title":"Nat Neurosci"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2013.114","article-title":"Common DNA methylation alterations in multiple brain regions in autism","volume":"19","author":"Ladd-Acosta","year":"2014","journal-title":"Mol Psychiatry"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiv277","article-title":"HIV-1 infection accelerates age according to the epigenetic clock","volume":"212","author":"Horvath","year":"2015","journal-title":"J Infect Dis"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1038\/s41514-022-00085-y","article-title":"A pan-tissue DNA-methylation epigenetic clock based on deep learning","volume":"8","author":"De Lima Camillo","year":"2022","journal-title":"NPJ Aging"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.18632\/aging.101508","article-title":"Epigenetic clock for skin and blood cells applied to Hutchinson Gilford Progeria Syndrome and ex vivo studies","volume":"10","author":"Horvath","year":"2018","journal-title":"Aging"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awaa334","article-title":"Recalibrating the epigenetic clock: implications for assessing biological age in the human cortex","volume":"143","author":"Shireby","year":"2020","journal-title":"Brain"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.18632\/aging.101684","article-title":"DNA methylation GrimAge strongly predicts lifespan and healthspan","volume":"11","author":"Lu","year":"2019","journal-title":"Aging"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.18632\/aging.204434","article-title":"DNA methylation GrimAge version 2","volume":"14","author":"Lu","year":"2022","journal-title":"Aging"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.18632\/aging.101414","article-title":"An epigenetic biomarker of aging for lifespan and healthspan","volume":"10","author":"Levine","year":"2018","journal-title":"Aging"},{"key":"B72","doi-asserted-by":"publisher","first-page":"394","DOI":"10.18632\/aging.100908","article-title":"DNA methylation levels at individual age-associated CpG sites can be indicative for life expectancy","volume":"8","author":"Lin","year":"2016","journal-title":"Aging"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1038\/s43587-023-00557-0","article-title":"Causality-enriched epigenetic age uncouples damage and adaptation","volume":"4","author":"Ying","year":"2024","journal-title":"Nat Aging"},{"key":"B74","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1038\/s43587-024-00600-8","article-title":"Quantifying the stochastic component of epigenetic aging","volume":"4","author":"Tong","year":"2024","journal-title":"Nat Aging"},{"key":"B75","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s13059-016-1064-3","article-title":"Correlation of an epigenetic mitotic clock with cancer risk","volume":"17","author":"Yang","year":"2016","journal-title":"Genome Biol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"4211","DOI":"10.1038\/s41467-024-48649-8","article-title":"An improved epigenetic counter to track mitotic age in normal and precancerous tissues","volume":"15","author":"Zhu","year":"2024","journal-title":"Nat Commun"},{"key":"B77","doi-asserted-by":"publisher","first-page":"6659","DOI":"10.1038\/s41467-022-34268-8","article-title":"Cell division drives DNA methylation loss in late-replicating domains in primary human cells","volume":"13","author":"Endicott","year":"2022","journal-title":"Nat Commun"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.18632\/aging.102173","article-title":"DNA methylation-based estimator of telomere length","volume":"11","author":"Lu","year":"2019","journal-title":"Aging"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btae200","article-title":"pyaging: a Python-based compendium of GPU-optimized aging clocks","volume":"40","author":"De Lima Camillo","year":"2024","journal-title":"Bioinformatics"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1111\/ejn.15661","article-title":"A comparison of blood and brain\u2010derived ageing and inflammation\u2010related DNA methylation signatures and their association with microglial burdens","volume":"56","author":"Stevenson","year":"2022","journal-title":"Eur J Neurosci"},{"key":"B81","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1186\/s12935-022-02834-1","article-title":"Cell senescence-associated genes predict the Malignant characteristics of glioblastoma","volume":"22","author":"Tan","year":"2022","journal-title":"Cancer Cell Int"},{"key":"B82","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1038\/s41419-025-07915-3","article-title":"Profiling with senescence-associated secretory phenotype score identifies GDC-0879 as a small molecule sensitizing glioblastoma to anti-PD1","volume":"16","author":"Liu","year":"2025","journal-title":"Cell Death Dis"},{"key":"B83","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/s41467-023-36124-9","article-title":"Cellular senescence in Malignant cells promotes tumor progression in mouse and patient glioblastoma","volume":"14","author":"Salam","year":"2023","journal-title":"Nat Commun"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-026-04541-y","article-title":"Integrated biomarker mapping reveals differential expression of senescence profiles in IDH-wild-type glioblastoma recurrent versus primary tumors","author":"Al Shboul","year":"2026","journal-title":"Virchows Arch"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.645593","article-title":"Mechanisms of cellular senescence: Cell cycle arrest and senescence associated secretory phenotype","volume":"9","author":"Kumari","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.3390\/cells13151281","article-title":"Therapy-induced cellular senescence: Potentiating tumor elimination or driving cancer resistance and recurrence","volume":"13","author":"Liu","year":"2024","journal-title":"Cells"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.18632\/aging.102172","article-title":"The senescence-associated secretory phenotype (SASP) from mesenchymal stromal cells impairs growth of immortalized prostate cells but has no effect on metastatic prostatic cancer cells","volume":"11","author":"Alessio","year":"2019","journal-title":"Aging"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1186\/s41232-022-00197-8","article-title":"The roles and mechanisms of senescence-associated secretory phenotype (SASP): Can it be controlled by senolysis","volume":"42","author":"Ohtani","year":"2022","journal-title":"Inflammation Regener"},{"key":"B89","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1186\/s12943-025-02475-8","article-title":"The controversial role of senescence-associated secretory phenotype (SASP) in cancer therapy","volume":"24","author":"Cao","year":"2025","journal-title":"Mol Cancer"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1441460","article-title":"Challenges and advances in glioblastoma targeted therapy: The promise of drug repurposing and biomarker exploration","volume":"14","author":"Bae","year":"2024","journal-title":"Front Oncol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2023.1327621","article-title":"Overcoming challenges in glioblastoma treatment: Targeting infiltrating cancer cells and harnessing the tumor microenvironment","volume":"17","author":"Chiariello","year":"2023","journal-title":"Front Cell Neurosci"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-024-01226-x","article-title":"Immunotherapy for glioblastoma: Current state, challenges, and future perspectives","volume":"21","author":"Liu","year":"2024","journal-title":"Cell Mol Immunol"},{"key":"B93","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1007\/s11060-025-05315-3","article-title":"Immunotherapy and targeted therapy for high grade gliomas: Current and future directions","volume":"176","author":"Hsueh","year":"2026","journal-title":"J Neuro-Oncol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01349","article-title":"Neutrophils in gliomas","volume":"8","author":"Massara","year":"2017","journal-title":"Front Immunol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1665742","article-title":"Emerging insights into the immunosuppressive tumor microenvironment and its implications for glioblastoma immunotherapy","volume":"16","author":"Nicolaou","year":"2025","journal-title":"Front Immunol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1605346","article-title":"Research landscape of glioma and inflammation over the past two decades","volume":"16","author":"Chen","year":"2025","journal-title":"Front Immunol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2020.02.002","article-title":"Immunotherapy for glioma: Current management and future application","volume":"476","author":"Xu","year":"2020","journal-title":"Cancer Lett"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1690464","article-title":"Recent advances in immunotherapy for gliomas: Overcoming barriers and advancing precision strategies","volume":"16","author":"Jabri","year":"2026","journal-title":"Front Immunol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1038\/nature10866","article-title":"IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype","volume":"483","author":"Turcan","year":"2012","journal-title":"Nature"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(97)00062-2","article-title":"A survey of telomerase activity in human cancer","volume":"33","author":"Shay","year":"1997","journal-title":"Eur J Cancer"},{"key":"B101","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.brainres.2006.11.093","article-title":"Telomerase subunits expression variation between biopsy samples and cell lines derived from Malignant glioma","volume":"1134","author":"Shervington","year":"2007","journal-title":"Brain Res"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2008.04.027","article-title":"Differential hTERT mRNA processing between young and older glioma patients","volume":"582","author":"Shervington","year":"2008","journal-title":"FEBS Lett"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1038\/nrm.2016.171","article-title":"Telomeres in cancer: tumour suppression and genome instability","volume":"18","author":"Maciejowski","year":"2017","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a041688","article-title":"Telomere crisis shapes cancer evolution","volume":"18","author":"Nassour","year":"2026","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B105","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1038\/s41467-021-21933-7","article-title":"Structural variant evolution after telomere crisis","volume":"12","author":"Dewhurst","year":"2021","journal-title":"Nat Commun"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nos329","article-title":"Prognostic significance of telomerase-associated parameters in glioblastoma: effect of patient age","volume":"15","author":"L\u00f6tsch","year":"2013","journal-title":"Neuro-Oncol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-2050","article-title":"Longitudinal assessment of genetic and epigenetic markers in oligodendrogliomas","volume":"13","author":"Lavon","year":"2007","journal-title":"Clin Cancer Res"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.00200","article-title":"The coincidence between increasing age, immunosuppression, and the incidence of patients with glioblastoma","volume":"10","author":"Ladomersky","year":"2019","journal-title":"Front Pharmacol"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.925469","article-title":"Inflammatory aging clock: a cancer clock to characterize the patients\u2019 subtypes and predict the overall survival in glioblastoma","volume":"13","author":"Zhu","year":"2022","journal-title":"Front Genet"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1898095\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T05:53:31Z","timestamp":1784699611000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1898095\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":109,"alternative-id":["10.3389\/fimmu.2026.1898095"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1898095","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]},"article-number":"1898095"}}